XTL BIOPHARMACEUTICALS LTD.

Highlights XTL Biopharmaceuticals Ltd.

Equities

XTLB

IL0010854979

Delayed TEL AVIV STOCK EXCHANGE Other stock markets 05:11:09 2024-05-29 EDT			5-day change	1st Jan Change
9.2 ^ILa	-3.16%		-7.07%	+162.86%

04-30	XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04-29	Top Premarket Gainers	MT

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-30	CI
Top Premarket Gainers	04-29	MT
Top Midday Gainers	03-20	MT
XTL Biopharmaceuticals to Acquire The Social Proxy; Shares Soar	03-20	MT
XTL Biopharmaceuticals Ltd. entered into a binding term sheet to acquire THE SOCIAL PROXY Ltd.	03-19	CI
XTL Biopharmaceuticals Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	11-15	CI
XTL Biopharmaceuticals Ltd. Unveils Expanded hCDR1 Preclinical Data for the Treatment of Sjögren’s Syndrome	17-04-05	CI
XTL Biopharmaceuticals Ltd. Reports Audited Consolidated Earnings Results for the Full Year Ended December 31, 2016	17-03-30	CI
XTL Biopharmaceuticals Ltd. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2016	16-12-06	CI
XTL Biopharmaceuticals Ltd. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2016	16-09-27	CI
XTL Biopharmaceuticals Announces New Patent Filing in U.S. for Lupus Drug hCDR1	16-08-11	CI
XTL Biopharmaceuticals Ltd. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2016	16-06-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer